|
|
|
| Accurate HEK293 Residual DNA Quantification with Vericheck ddPCR™ | Ensure precise and reliable measurement of HEK293 residual DNA in biopharmaceutical production with the VeriCheck™ ddPCR™ HEK293 Residual DNA Quantification Kit. Leveraging Droplet Digital™ PCR technology, this kit delivers superior sensitivity and accuracy, meeting regulatory compliance needs. Simplify your workflow with a robust, easy-to-use solution for confident decision-making. Discover how VeriCheck can enhance your residual DNA testing. Order now. |
|
|
|
|
By Tiffany Lucas, Ph.D., and Ifty Saiyed, Eliquent Life Sciences | The U.K.'s MHRA has released a new draft guideline outlining best practices for drug product design, CMC, and manufacturing of mRNA cancer immunotherapies using LNP delivery systems. The public comment period ends March 31. | |
|
|
|
| 4 Factors To Consider When Scaling Up | Article | By Josh Russell, AST | It's essential to understand how scaling up is affecting your aseptic filling operations. Here are four topics to consider to help ensure your drug product will be taken care of and ready for production. |
|
|
| Improving The Efficacy Of T Cell Therapies | Article | By Brad N. Taylor, Ph.D., Nucleus Biologics | CAR-T cell therapy is evolving rapidly, with scientists exploring new ways to improve efficacy, safety, and applicability. Precision media formulation plays a key role in optimizing therapeutic cell quality. |
|
|
| Cell Culture Media Change Protocol | Article | Corning Life Sciences | Keep your cells thriving. Learn the essential cell culture media change protocol, including frequency, steps, and tips for optimal cell growth. Discover best practices and avoid common pitfalls. |
|
|
| Simpler, Faster, Cheaper Advanced Therapy Manufacturing | Application Note | Repligen | Discover how TFDF-based perfusion technology boosts lentiviral vector production by over 10-fold, slashes costs, and accelerates the commercialization of CAR-T and other advanced cell therapies. |
|
|
|
| Optimizing Safety Measures For rAAV Therapies | White Paper | MilliporeSigma | Explore common process-related impurities found in recombinant Adeno-Associated Virus (rAAV) vectors and the analytical testing methods used for these residuals. |
|
|
|
|
| Optimizing AAV Purification for High Recovery | White Paper | By Tiago Faria, Andrew Nascimeto, Cristina Peixoto, Sharon Bola, and William H. Rushton, Bio-Rad Laboratories, Inc. | How can you improve purification methods for your AAVs and enhance the efficacy and safety of your gene therapy treatments? |
|
|
|
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
